ReviewJournal of cancer research and clinical oncology2018

Lentinan as an immunotherapeutic for treating lung cancer: a review of 12 years clinical studies in China.

Yiran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.